Lactoferrin Dosage: 100mg to 800mg, and Why More Isn't Better
Educational summary — not medical advice. Lactoferrin has no established RDA or upper limit, and no consistent human timing/food data across the trials in this pack. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
The honest answer
The dose depends on which evidence you're chasing. 100–250 mg/day covers the iron/anemia trial range. The most current general-immune RCT (Berthon 2026) tested 200 mg and 600 mg/day arms. The two dedicated COVID-19 trials went as high as 600–800 mg/day — and still found no clinical benefit, a genuine "more isn't automatically better" data point. Most retail capsules deliver 250–300 mg/day at 1 capsule/day, inside the iron and immune trial range. There's no RDA or upper limit — lactoferrin isn't an essential nutrient.
Dose by use case, read carefully
Lactoferrin doesn't have one settled dose, and the honest approach is matching the dose to the specific evidence, not defaulting to the biggest number on the shelf. For iron status, the surviving systematic review (Christofi et al. 2024) reports its pooled trials generally used 100-250mg/day (though its pooled estimate carries very high statistical heterogeneity, I²=95.8% — a noisy signal, not a clean one); the one non-retracted primary pregnancy-anemia trial (Nappi et al. 2009) doesn't itemize its exact daily dose in the fetched abstract, so state it as "roughly 100-200mg/day," typical of the pregnancy-anemia trials, rather than a single precise figure. For general immune support, the most current and highest-quality trial (Berthon et al. 2026, healthy adults 50+) tested 200mg and 600mg/day arms against placebo over 4 weeks, measuring inflammatory markers and immune-cell profiles — surrogate endpoints, not a clinical "fewer infections" outcome. For COVID-19 specifically, the two dedicated RCTs used the highest doses in this evidence base: 600mg/day for 90 days in healthcare workers (Navarro et al. 2023) and 800mg/day in hospitalized patients (Matino et al. 2023) — both trials missed their primary clinical endpoints despite the higher doses, a real and useful "dose isn't the bottleneck" data point.
| Use case | Dose studied | Result |
|---|---|---|
| Iron/anemia (pooled) | 100-250 mg/day | Hemoglobin favored lactoferrin in pooled data, but I²=95.8% heterogeneity (Christofi 2024) — a noisy signal, not a clean one. |
| Iron/anemia (single surviving primary trial) | ~100-200 mg/day, 30 days | Matched ferrous sulfate on hemoglobin/ferritin; fewer GI side effects (Nappi 2009, n=97, not retracted). |
| General immune, low dose | 200 mg/day, 4 weeks | Reduced neutrophil frequency and activated CD8+ T cells vs placebo (Berthon 2026) — lab-marker endpoints. |
| General immune, high dose | 600 mg/day, 4 weeks | Reduced IL-6/CRP vs low dose; blunted rhinovirus-challenge IL-6 response (Berthon 2026) — lab-marker/ex-vivo endpoints. |
| COVID-19 prevention | 600 mg/day, 90 days | Primary endpoint NOT MET — infection rate numerically higher with lactoferrin (Navarro 2023). |
| COVID-19 hospitalized | 800 mg/day | Both primary endpoints (death/ICU, discharge/recovery) NOT MET (Matino 2023). Authors: findings "do not support its use." |
How to think about it
- 250-300mg/day is the typical retail serving, and it sits comfortably inside the iron and general-immune trial range — a reasonable default if you're taking lactoferrin at all.
- Higher doses (600-800mg/day) have not been shown to work better. The two trials that pushed dose the highest — specifically to test a clinical outcome (COVID-19 prevention and hospitalized-patient recovery) — both came back null. Don't assume doubling your dose buys anything.
- No established RDA or upper limit exists, because lactoferrin is not an essential nutrient. The reference points here are trial doses, not government-set targets.
- Form note: most retail bovine lactoferrin is apolactoferrin (the iron-depleted form) or close to it, but labels rarely disclose iron-saturation percentage — see best lactoferrin for which product actually names it.
- Timing: no consistent human timing/food data exists across the trials in this pack. Take it with or without food, per the label, rather than following an invented timing rule.
- Milk-allergy caution: lactoferrin is a milk-derived protein. Anyone with a diagnosed cow's-milk-protein allergy should not assume it's safe by default.
Picks by dose & form
Full ranking, including cost per mg and cost per day, is on best lactoferrin.
Inside the 100-250mg iron-trial range and the 200-600mg immune-trial range.
The only tracked product naming the apolactoferrin form used in most immune trials.
As an Amazon Associate we earn from qualifying purchases. Of 5 products tracked; ranked by cost, never commissions.
Frequently asked questions
How much lactoferrin should I take per day?
100-250mg/day for iron-related evidence; 200-600mg/day in the most current immune RCT. Most retail capsules are 250-300mg/day. No RDA or upper limit exists.
Is a higher lactoferrin dose better?
Not demonstrably — the two COVID-19 trials used the highest doses (600-800mg/day) and both were null on their primary endpoints.
What dose was used in the pregnancy-anemia trials?
Roughly 100-200mg/day in the surviving primary trial (Nappi 2009); 100-250mg/day in the pooled systematic review. The two largest, most specific trials in this niche were retracted in Dec 2023.
Is there an RDA or upper limit for lactoferrin?
No — not an essential nutrient. Reference points are trial doses (100-800mg/day by use case), not a regulatory limit.
Related
- Lactoferrin: what it is & who it's for
- Best lactoferrin — ranked by cost per mg and per day
- Lactoferrin for iron-deficiency anemia
- Does lactoferrin boost immunity?
Sources
- Christofi MD, et al. "The effectiveness of oral bovine lactoferrin compared to iron supplementation in patients with a low hemoglobin profile: A systematic review and meta-analysis of randomized clinical trials." BMC Nutrition. 2024. PMID: 38291525 (100-250 mg/day pooled range; ⚠️ I²=95.8% heterogeneity).
- Nappi RE, et al. "Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study." Acta Obstetricia et Gynecologica Scandinavica. 2009. PMID: 19639462 (~100-200 mg/day, not itemized precisely).
- Berthon BS, et al. "Oral lactoferrin reduces systemic inflammation, enhances anti-viral responses and modulates immune cell profiles: a randomised controlled trial in healthy, older adults." The British Journal of Nutrition. 2026. PMID: 41634901 (200/600 mg/day).
- Navarro G, et al. "Bovine lactoferrin for the prevention of COVID-19 infection in health care personnel: a double-blinded randomized clinical trial (LF-COVID)." Biometals. 2023. PMID: 36474100 (600 mg/day, 90 days).
- Matino E, et al. "Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial." Nutrients. 2023. PMID: 36904283 (800 mg/day).
- Full product dataset: /lactoferrin/cost-by-brand.json (CC BY 4.0).